Rezo is a different kind of biopharma company. Our mission is to dramatically increase the success rate of drug development by building a disease-agnostic, fully-integrated, network biology platform that will redefine our understanding of human disease and ability to treat it.


Biotechnology

Research

Rezo Therapeutics

Nevan Krogan

Senior Scientist, Medicinal Chemistry

Todd Daigle

Chris Adams

Alejandro Ramirez

Katherine Schutt

Kevin Hu

Simranjit Singh

Peggy Ackerberg

Krystal Fontaine

Ali Bashir

Sourav Bandyopadhyay

The Scientific Research and Development team at Rezo Therapeutics focuses on leveraging network biology to enhance drug development success. This interdisciplinary group, inclusive of experts in chemistry, proteomics, computational biology, AI, and program management, collaborates to validate biological targets, discover new therapies, and optimize research processes. Their integrated approach aims to redefine the understanding and treatment of human diseases.

Scientific Research and Development

Leadership Team

Scientific Research and Development

About

Team members

Other teams at Rezo Therapeutics

Leadership Team